Indeed, rare variants in the NF-κB inhibitor TNFAIP3 (A20) have recently been associated with a BEH-like familial disease [75] and variants contributing to dysregulation of NF-κB signalling may thus also contribute to the more common form of BEH. This evidence concerns the gene TNFAIP3 and familial disease.